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ABSTRACT Surfactant protein B (SP-B) is an essential component of pulmonary surfactant. Synthetic surfactant peptide KL4, a
peptidebasedonaC-terminal amphipathic helical regionof humanSP-B,efﬁcientlymimics some functional propertiesofSP-Band is
included in therapeutic surfactant preparations used in trials to treat respiratory distress syndrome. The membrane orientation of
this peptide is controversial. We used an in vitro transcription-translation system to study the insertion of hydrophobic sequences
intomicrosomalmembranes, and showed that theKL4 sequence integrates efﬁcientlywith a transmembrane orientationdespite the
presenceof intermittent lysines throughout the sequence. In contrast, the precise sequenceof theC-terminalSP-Bamphipathic region
failed to integrate, indicating a nontransmembrane orientation. Differences in the membrane insertion between KL4 and the SP-B-
inspiring sequence match predictions from calculated free energies of insertion of the two sequences into membranes.
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Pulmonary surfactant is a mixture of lipids and proteins that
lowers surface tension at the air/liquid interface, thereby
reducing the work involved in breathing and reducing the
risk of collapse at expiration. The main lipid constituent and
surface tension-reducing component is dipalmitoylphospha-
tidylcholine (1). Dipalmitoylphosphatidylcholine, however,
is extremely inefﬁcient at adsorbing into the interface. Two
small hydrophobic proteins, surfactant protein B (SP-B) and
surfactant protein C (SP-C), facilitate the rapid movement of
lipids between membranes and the interface and help respread
the compressed state of the ﬁlms during subsequent cycling
(2). Surfactant membranes also contain anionic phosphatidyl-
glycerol, which is thought to establish functionally important
interactions with cationic SP-B and SP-C (3).
Pulmonary surfactant is essential for survival, and its
deﬁciency or dysfunction contributes to severe respiratory
pathologies such as infant respiratory distress syndrome
(IRDS) in neonates or acute respiratory distress syndrome.
Surfactant therapy using exogenous surfactants is a routine
clinical procedure for the prevention and treatment of IRDS.
The hydrophobic SP-B and SP-C proteins are essential
components for the physiological activity of most clinical
surfactants (4), which are obtained from animal sources.
Because the use of animal-derived surfactants bears serious
concerns in terms of potential infections, immunological
responses, and compositional consistency, the development
of synthetic surfactants is a topic of intense investigation (5).
The structural complexity of SP-B has thus far precluded
the expression of functionally active recombinant SP-B. How-
ever, synthetic surfactants that contain peptide mimics of SP-B
segments have been developed (Surfaxin), exhibiting some
efﬁcacy in cases of IRDS (6). The peptide included in this
synthetic surfactant (KL4) was based on the C-terminal region
of mature SP-B, a hydrophobic sequence with intermittent
positively charged residues, which improved the interfacial
activity of synthetic phospholipids (7). KL4 was designed as
a similar sequence pattern of hydrophobic/cationic residues,
consisting of a stretch of four hydrophobic leucines inter-
spersed with cationic lysine to create a 21-residue sequence
([lysine-(leucine)4]4-lysine). KL4 has been proposed to stabi-
lize interfacial lipid layers via electrostatic interactions
between the lysines and anionic headgroups, and hydrophobic
interactions between the leucines and the phospholipid acyl
chains (8). Nevertheless, the real orientation of this synthetic
peptide in surfactant membranes and ﬁlms has been a topic of
discussion. KL4 exhibited a high a-helical content as studied
by infrared and circular dichroism spectroscopies in the
presence of micelles or bilayers, and exhibited an orientation
parallel to the lipid acyl chains in bilayers (9). In contrast,
infrared reﬂection-absorption spectroscopy studies showed an
antiparallel b-sheet structure of KL4 in interfacial ﬁlms with a
transition toward an a-helical conformation in the interfacial
region of multilayers formed under compression (10). Con-
formation and lipid-protein interactions of KL4 depend on
membrane lipid composition, bilayer packing density, and
peptide concentration in the membrane (11,12). Thus, further
studies are needed to determine the exact secondary structure
and orientation of KL4 in biological membranes. This study
examined the ability of the KL4 peptide sequence to integrate
into endoplasmic reticulum (ER) membranes and compared its
behavior with that of the SP-B sequence that inspired its design.
The membrane insertion capacity of the surfactant KL4
peptide was investigated using an experimental system based
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on the Escherichia coli inner membrane protein leader
peptidase (Lep), which accurately reports the integration of
transmembrane (TM) helices into ER membranes (13). Lep
consists of two TM segments connected by a cytoplasmic
loop (P1) and a large C-terminal domain (P2), and inserts
into ER-derived microsomal membranes (MMs) with both
termini located in the lumen (Fig. 1 A). The segment ana-
lyzed (H-segment) is engineered into the luminal P2 domain
and is ﬂanked by two acceptor sites (G1 and G2) for N-linked
glycosylation. Single glycosylation (i.e., membrane integra-
tion) results in a molecular mass increase of ;2.5 kDa
relative to the observed molecular mass of Lep expressed in
the absence of microsomes; the molecular mass shifted
;5 kDa upon double glycosylation (i.e., membrane trans-
location of the H-segment). Proteinase K (PK) added to MM
vesicles will digest the cytoplasmic exposed, nonglycosy-
lated form of the P2 domain (Fig. 1 A, left) to produce a
protected, double-glycosylated P2 fragment when the P2
domain is located in the lumen of the MMs (Fig. 1 A, right).
Given the amino acid sequence of an H-segment, TM
orientation can be predicted using the apparent free energy
difference (DGapp) for insertion into ER membranes (14). The
predicted DGapp for the KL4 sequence was computed as2.14
kcal/mol (Fig. 1 C, calculated using the DG Prediction Server
v1.0, http://www.cbr.su.se/DGpred/) (13,14). The negative
DGapp predicts the KL4 sequence as a TM segment, resembling
the TM orientation of surfactant protein SP-C (15) rather than
SP-B in termsofERmembrane integration. In fact, sequence13–
35 of SP-C (Fig. 1 B) is predicted to be TM (Fig. 1 C), whereas
the SP-B segment that inspired KL4 (segment 59–79; Fig. 1 B)
is predicted to not be integrated into membranes (Fig. 1 C).
The translation of constructs harboring the KL4 sequence
(constructed using double-stranded oligonucleotides as previ-
ously described (16)) clearly resulted in single glycosylated
forms (Fig. 1 D, lane 2). PK treatment of this sample rendered
complete loss of detectable fragments (Fig. 1 D, lane 3),
conﬁrming membrane integration of the KL4 sequence. The
dispersion of charged lysine residues in the KL4 sequence
around the circumference of the helix (Fig. 1 E, left) has been
argued to inhibit partition of the peptide into the core of the
bilayer (10). Nevertheless, the strong hydrophobic contribu-
tion of the abundant leucine residues in KL4 may reduce the
free energy of membrane integration. Interestingly, recent
computer simulation studies suggest that the transfer of ;4
leucines from water to the bilayer interior could be sufﬁcient
to balance the transfer of a cationic residue (17). Translation of
a construct bearing the TM segment of SP-C in the presence of
MMs yielded single-glycosylated forms sensitive to PK di-
gestion (Fig. 1D, lanes 5 and 6), indicative of TM integration.
We also examined the SP-B 59–79 sequence. As shown in
Fig. 1 D (lanes 7–9), translation of this construct in the
presence of MMs rendered double-glycosylated forms (lane
8), and PK treatment of this sample generated a protected
double-glycosylated P2 fragment (lane 9), indicating mem-
brane translocation of this H-segment.
One possibility is that the particular chemical character of
lysine residues may be important for the membrane integration
process of TM segments. To test this idea, we replaced the
central lysine residue inKL4with either aspartic acid or arginine.
As shown in Fig. S1 of the Supplementary Material, both
sequences inserted in the membrane in a manner similar to KL4
(lanes 2–4), in good agreement with computed values, arguing
against speciﬁc effects of the lysine itself. Furthermore, insertion
of a second lysine in the central region of the KL4 sequence,
which reduced the predicted DGapp by 1.62 kcal/mol (Fig. S1),
retained insertion of;85% of the molecules (Fig. S1, lane 5).
As stated, somecontroversy surrounds the actual orientation of
KL4 peptide in surfactant membranes and ﬁlms (18,19). Despite
the fact that this peptide was originally designed to mimic
FIGURE 1 (A) Schematic of the engineered leader peptidase
(Lep) model protein. (B) The H-segment sequences examined
in this study. (C) Calculated DGapp values for the assessed
sequences using the DG Prediction Server (see text). (D) In vitro
translation in the presence (1) or absence () of MMs and PK.
Nonglycosylated protein bands are indicated by a white dot;
single and double glycosylated proteins are indicated by one and
two black dots, respectively. The protected double-glycosylated
P2 fragment is indicated by an asterisk (*). (E) Left, KL4 canonical
helix structure. Center, SP-C helical region (residues 13–35) from
the structure determined by NMR (Protein Data Bank: 1SPF) (15).
Right, SP-B region (residues 63–78) based on the structure of
Mini-B in sodium dodecylsulfate micelles (Protein Data Bank
code: 2DWF). Side chains of Arg and Lys residues are shown.
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amphipathic peripheral helices in SP-B, signiﬁcant structural
differences exist between KL4 and the C-terminal amphipathic
helices ofSP-B. In fact, amodel of theSP-B63–78 residue region
based on the structure ofMini-B (a minimized version of the SP-
B protein, Protein Data Bank code 2DWF) (20) shows a
noncanonical helix conformation with an amphipathic distribu-
tion of the cationic residues (Fig. 1 E, right), which can account
for thenonintegrationeffect observed inour experimental system.
This work shows that KL4 adopts a TM orientation in
MMs, and therefore can hardly be considered as an analog of
surfactant protein SP-B. However, as a TM peptide, KL4
could still efﬁciently promote the transfer of phospholipids
from bilayers into interfacial ﬁlms, similar to SP-C (21).
Whether KL4 could be actually transferred into the interface
upon adsorption of peptide/lipid complexes remains to be
demonstrated. Most studies have characterized the interfacial
behavior of SP-C or KL4 in ﬁlms formed from lipid/peptide
organic mixtures, which may not entirely reﬂect their
behavior when ﬁlms are formed from lipid/peptide aqueous
suspensions. SP-B has been suggested to have an active role
in stabilizing compressed interfacial structures, contributing
to reach the lowest tensions required to stabilize respiratory
mechanics (22). The structure of KL4 was proposed to mimic
the electrostatic and hydrophobic interactions associated
with high mechanical stability in SP-B-containing ﬁlms (8).
Our results suggest that the analogy between the behavior of
KL4 and SP-B at the interface has yet to be demonstrated,
particularly in ﬁlms formed from lipid/protein structures
in which the two polypeptides could have very different
orientations. Further studies will explore the minimal se-
quence variations required for KL4-like peptides to mimic
the orientation of SP-B sequences with respect to membranes
and the dependence of parameters deﬁning optimal surfac-
tant activity on speciﬁc peptide-membrane orientations.
SUPPLEMENTARY MATERIAL
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